Juvenile depression treatment with antidepressants from the selective serotonin reuptake inhibitors group

Authors

  • Ramil F Suleymanov Kazan Innovative University named after V.G. Timiryasov (IEML), Kazan, Russia
  • Roman V Gorenkov Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia
  • Natalya P Chernus Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia
  • Sergey A Orlov Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia
  • Irina F Kalinina Moscow Region «University of technology», Korolev, Russia

DOI:

https://doi.org/10.3329/bjms.v18i3.41637

Keywords:

juvenile depression; therapy; selective serotonin reuptake inhibitors; Paroxetine; Citalopram; Fluoxetine; Sertralin; Fluvoxamine

Abstract

Objective. The article presents the juvenile depression treatment effectiveness with antidepressants of the selective serotonin reuptake inhibitors group (SSRIs).

Materials and methods.182 patients were examined, including 114 men (62.6%) and 68 women (37.4%), age range 16 to 25 years, on treatment in a psycho-neurological dispensary in the city of Korolev (Russia, Moscow region) from 2014 to 2018.

Results and Discussion.Main characteristics comparison of SSRIs antidepressants therapeutic effect in young men and adults of mature age revealed statistically significant age differences concerning the onset rate and these drugs antidepressant effect characteristics, as well as the adverse events nature.

Conclusion. The SSRIs antidepressants clinical action regularities for depression treatment in adolescence, their therapeutic effect features and dynamics allow us to state adequate indications for the these drugs administration in adolescence, considering their age specificity.

Bangladesh Journal of Medical Science Vol.18(3) 2019 p.615-623

Downloads

Download data is not yet available.
Abstract
40
PDF
42

Downloads

Published

2019-05-30

How to Cite

Suleymanov, R. F., Gorenkov, R. V., Chernus, N. P., Orlov, S. A., & Kalinina, I. F. (2019). Juvenile depression treatment with antidepressants from the selective serotonin reuptake inhibitors group. Bangladesh Journal of Medical Science, 18(3), 615–623. https://doi.org/10.3329/bjms.v18i3.41637

Issue

Vol. 18 No. 3 (2019)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.